eHealth Market (By Product: ePrescribing, EHR, Telemedicine, mHealth, Clinical Decision Support, Others; By Service: Diagnostic, Monitoring, Healthcare Strengthening, Treatment, Database Management; By End Use: Healthcare Providers, Insurers, Healthcare Consumers, Government; By Deployment: On-premise, Cloud-based) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: EHealth Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. EHealth Market, by Product Type, 2023-2032
8.1.1. ePrescribing
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. EHR
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Telemedicine
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.4. mHealth
8.1.4.1. Market Revenue and Forecast (2021-2032)
8.1.5. Health Management
8.1.5.1. Market Revenue and Forecast (2021-2032)
8.1.6. Clinical Decision Support
8.1.6.1. Market Revenue and Forecast (2021-2032)
8.1.7. Information System
8.1.7.1. Market Revenue and Forecast (2021-2032)
8.1.8. Radiology Information Systems
8.1.8.1. Market Revenue and Forecast (2021-2032)
8.1.9. Laboratory Information Systems
8.1.9.1. Market Revenue and Forecast (2021-2032)
8.1.10. Cardiovascular Information Systems
8.1.10.1. Market Revenue and Forecast (2021-2032)
8.1.11. Others
8.1.11.1. Market Revenue and Forecast (2021-2032)
9.1. EHealth Market, by Service, 2023-2032
9.1.1. Diagnostic
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Monitoring
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Healthcare Strengthening
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Treatment
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. Database Management
9.1.5.1. Market Revenue and Forecast (2021-2032)
10.1. EHealth Market, by End Use Type, 2023-2032
10.1.1. Healthcare Providers
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Insurers
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Healthcare Consumers
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Government
10.1.4.1. Market Revenue and Forecast (2021-2032)
11.1. EHealth Market, by Deployment Type, 2023-2032
11.1.1. On-premise
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Cloud-based
11.1.2.1. Market Revenue and Forecast (2021-2032)
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2032)
12.1.2. Market Revenue and Forecast, by Service (2021-2032)
12.1.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.1.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.1.5.2. Market Revenue and Forecast, by Service (2021-2032)
12.1.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.1.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.1.6.2. Market Revenue and Forecast, by Service (2021-2032)
12.1.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.1.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.2. Market Revenue and Forecast, by Service (2021-2032)
12.2.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.2.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.5.2. Market Revenue and Forecast, by Service (2021-2032)
12.2.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.2.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.6.2. Market Revenue and Forecast, by Service (2021-2032)
12.2.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.2.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.7.2. Market Revenue and Forecast, by Service (2021-2032)
12.2.7.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.2.7.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2032)
12.2.8.2. Market Revenue and Forecast, by Service (2021-2032)
12.2.8.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.2.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.2. Market Revenue and Forecast, by Service (2021-2032)
12.3.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.3.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.5.2. Market Revenue and Forecast, by Service (2021-2032)
12.3.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.3.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.6.2. Market Revenue and Forecast, by Service (2021-2032)
12.3.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.3.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.7.2. Market Revenue and Forecast, by Service (2021-2032)
12.3.7.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.3.7.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2032)
12.3.8.2. Market Revenue and Forecast, by Service (2021-2032)
12.3.8.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.3.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.2. Market Revenue and Forecast, by Service (2021-2032)
12.4.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.4.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.5.2. Market Revenue and Forecast, by Service (2021-2032)
12.4.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.4.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.6.2. Market Revenue and Forecast, by Service (2021-2032)
12.4.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.4.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.7.2. Market Revenue and Forecast, by Service (2021-2032)
12.4.7.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.4.7.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2032)
12.4.8.2. Market Revenue and Forecast, by Service (2021-2032)
12.4.8.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.4.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.5.2. Market Revenue and Forecast, by Service (2021-2032)
12.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2032)
12.5.5.2. Market Revenue and Forecast, by Service (2021-2032)
12.5.5.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.5.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2032)
12.5.6.2. Market Revenue and Forecast, by Service (2021-2032)
12.5.6.3. Market Revenue and Forecast, by End Use Type (2021-2032)
12.5.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)
13.1. Allscripts Healthcare Solutions, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Koninklijke Philips N.V.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Siemens Healthineers
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. International Business Machines Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. General Electric Company
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. InTouch Health
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Athenahealth, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Cisco Systems, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. UnitedHealth Group
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medtronic plc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client